The $800 Million Pill: The Truth Behind the Cost of New DrugsBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7465.577 (Published 02 September 2004) Cite this as: BMJ 2004;329:577
- Jeff Aronson, reader in clinical pharmacology (email@example.com)
Two sets of statistics summarise the two main preoccupations of this book.
Firstly, the costs of drug development. The Tufts University Center for the Study of Drug Development calculated that in 2001 the pharmaceutical industry spent $802m (£446m; €663m) per marketed drug, while the Global Alliance for TB Drug Development thought that a new antituberculosis drug could be developed in the public sector for as little as $115m to $240m, conceding that the international …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial